Valproic acid Completed Phase 2 Trials for Retinal Degenerations / Retinitis Pigmentosa (RP) / Eye Diseases / Eye Disease, Hereditary / Retinal Diseases Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01399515Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa